- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2009
- Public Summary Document (PSD) March 2009 PBAC Meeting - PDF
Dabigatran etexilate mesilate – March 2009
Dabigatran etexilate mesilate, capsules, 75 mg, 110 mg (base), Pradaxa®, March 2009
Last updated
3 July 2009